Patent delisted for Boehringer Ingelheim drug JENTADUETO

Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents…

The post Patent delisted for Boehringer Ingelheim drug JENTADUETO appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Do NOT follow this link or you will be banned from the site!